As a caregiver to my mum, who has myeloma, I usually experience some moments of quietness. One of these moments might be when we’re…
Myeloma
The U.S. Food and Drug Administration (FDA) has granted fast track designation to HDP-101 (pamlectabart tismanitin), a multiple myeloma therapy currently in early clinical…
I am a longtime journalist with a firm belief that knowledge is power. My life’s work has been to answer the who, what, where, when,…
The U.S. Food and Drug Administration (FDA) has approved GSK‘s Blenrep (belantamab mafodotin) for adults with relapsed or refractory multiple myeloma. The approval…
“Let me know if you need anything.” No matter how well-intentioned that statement sounds, I personally believe it’s the most useless thing someone can say…
People with hard-to-treat myeloma given a combination of Tecvayli (teclistamab) and Darzalex Faspro (daratumumab and hyaluronidase-fihj) — both approved cancer therapies from…
My therapist advised me to engage in more meditation. A friend sent me a link to a YouTube channel dedicated to yoga. In the waiting…
Results from a clinical trial testing Exicure‘s therapy candidate burixafor (GPC-100) in stem cell transplants for people with myeloma are expected soon — and the developer…
The most peaceful part of my day starts around 10:36 p.m. That’s when my mother has taken her last pills, I’ve checked her vitals, and…
C4 Therapeutics and Pfizer are teaming up to evaluate whether combining C4’s investigational oral therapy cemsidomide with Pfizer’s approved multiple myeloma treatment Elrexfio…
Recent Posts
- Partners to collect real-world data to speed care for kids with AML
- Study finds home transfusions safe in hospice care for blood cancer
- Small acts of defiance are the ways we push back against disease
- Under-the-skin myeloma treatment linked to better survival in study
- Add-on therapy shows promise for hard-to-treat AML